Close

LOGIN

Remember me
Not a member?
or
Connect using:
Why BS?

We encourage visitors to register on Business Standard. Registering on the site is absolutely Free and offers you the following benefits.

Free Daily E-newsletter

Breaking News Alerts in your Inbox

Post Comments and Share your Feedback

Your Personal Business Standard Page

Free Portfolio of Stocks, Equity and Commodities Derivatives

Access Premium Services

Receive Selective Offers from our Third Party Premium Advertisers

Get Invited to Business Standard Events

Close

FORGOT PASSWORD?

Not a member?

Torrent Pharma Q4 net dips 27.56% to Rs 42.84 cr

Read more on:    Torrent pharma | BSE | NSE
Related News

Torrent Pharmaceuticals Ltd today said its consolidated net profit had declined by 27.56% to Rs 42.84 crore for the fourth quarter ended March 31, 2011, over the same period previous fiscal.

The company had a net profit of Rs 59.14 in the same period previous fiscal

The company's net sales rose to Rs 489.81 crore for the fourth quarter, compared to Rs 448.42 crore in the same period previous fiscal, Torrent Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).

For the year ended, March 31, 2011, the company posted a consolidated net profit of Rs 270.17 crore, up 16.85%, as against Rs 231.20 crore in the previous fiscal.

The Ahmedabad-based firm's net sales for the year rose to Rs 2,121.97 crore, compared to Rs 1,832.93 crore in the previous fiscal.

The company's board has recommended a normal annual dividend of Rs 6 per equity share of Rs 5 each and a special dividend of Rs 2 per equity share of Rs 5, it said.

Read more on:   
|
|

Read More

Hindalco: Not out of the woods yet

Hindalco Industries' stock declined about 2% to Rs 110.50 currently after its December 2012 performance failed to cheer the Street. While the ...

Back to Top

Quick Links

Back to Top